Articles Archives - Page 301 of 785

MondayAug 22, 2022 11:15 am

DGE 3rd Clinical Trial Agreement Forum to Discuss Important Changes Impacting CTA’S and Remote Monitoring Agreements

Professionals and executives of biopharma and medical device companies are invited to attend DGE’s 3rd Clinical Trial Agreement Forum, a virtual online livestream event, on September 29-30, 2022. The conference will discuss how the evolution of the virtual clinical trial landscape requires flexibility when designing and modifying clinical trial agreements (“CTAs”). Clinical trials have seen many changes with the advent of virtual clinical trials, where telemedicine and remote monitoring are used. Changes that impact the CTAs include incorporating cybersecurity language, more complicated indemnification, complexities of third-party contracting, and an increase in remote monitoring. The conference will provide insights into novel industry…

MondayAug 22, 2022 10:30 am

Correlate Infrastructure Partners Inc. (CIPI), a Driver of Highly Cost-effective Solutions for Energy Use Optimization, Sees Significant Revenue Growth in Q2 2022

Correlate posts significant increase in Q2 revenue from $1,584 in 2021 to $236,690 in 2022 Customer deposits have also increased, from $0 during the same period in 2021 to $1,114,154 in Q2 2022, while operating expenses have grown from $4,937 to $1,444,794 Correlate has attributed the growth to the increased emphasis on commercialization, a shift from previous quarters that focused on product development The company hopes to maintain the current trajectory in performance, mainly banking on helping its commercial customers increase their NOI while also maturing its aggressive acquisition strategy Correlate Infrastructure Partners (OTCQB: CIPI), earlier released its results for…

MondayAug 22, 2022 9:45 am

$4M Investment Provides Capital Injection for FingerMotion Inc. (NASDAQ: FNGR) Mobile Device Protection Strategy in China

New York-based institutional fund manager The Lind Partners has reached an investment agreement with mobile device technology innovator FingerMotion Inc. to provide FingerMotion $4 million that will advance its initiatives FingerMotion is focused on varied initiatives for serving China’s massive mobile device user market, its top priority being the rollout of an AppleCare-similar device protection plan the company expects to be popular with users Company CEO Martin Shen has stated the protection plan service has the highest potential to yield returns on capital investment in the shortest amount of time China has more than 450 million 5G mobile phone users…

MondayAug 22, 2022 9:00 am

Odyssey Health, Inc. (ODYY) Continues to Report Positive Results from Ongoing Phase I Clinical Trial Evaluating Safety, Efficacy of PRV-002 Concussion Drug Candidate

Odyssey Health is a medical company focused on developing unique, life-saving medical products that offer clinical advantages for unmet clinical needs Recently, the company reported positive results from Cohort I of its Multi-Day Ascending Dosing (“MAD”) portion of its Phase I clinical trial, coming weeks after the successful completion of Phase I Single Ascending Dosing (“SAD”) clinical trial The MAD arm thus far shows that the drug is safe and well tolerated Odyssey expects to report additional MAD results as they become available A few weeks after completing its Phase I Single Ascending Dosing (“SAD”) clinical trial, Odyssey Health (OTC:…

FridayAug 19, 2022 10:30 am

NECANN 3rd Annual New Jersey Cannabis Convention Brings the East Coast Cannabis Community under One Roof

The NECANN Conference has evolved into the largest conference on the East Coast, attracting cannabis cultivators, traders, regulators, lawmakers, and enthusiasts, from the East Coast and beyond. The 3rd annual New Jersey Cannabis Convention is being held from September 9-10, 2022, in Atlantic City, New Jersey. This is a well-curated event organized by a highly talented team of professionals with desired expertise and experience. They keep in mind the needs and requirements of the cannabis community and bring together investors, young and veteran cannabis and hemp traders, as well as researchers and lawmakers, all in a common forum. After fighting…

FridayAug 19, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Delighted About Well-Received DehydraTECH-CBD Proposals by the FDA; Maintains Late 2022/Early 2023 Target For Complete IND Application

Lexaria’s successful HYPER-H21-2 human clinical study, whose results were announced in the first week of September 2021, laid the groundwork for the company’s patented DehydraTECH(TM)-processed CBD NDA Chris Bunka, the company’s CEO, referred to the results as “statistically significant,” ultimately kickstarting the IND application process with the FDA Lexaria has since received a full written positive response from the FDA on its DehydraTECH-CBD, agreeing to the company’s proposal to pursue the 505(b)(2) NDA regulatory pathway As a result of the favorable FDA response, Lexaria expects to remain on track to file its full IND application, 6-9 months sooner than if…

FridayAug 19, 2022 9:00 am

Cepton, Inc. (NASDAQ: CPTN) Sees Lidar’s Uses Expand, Maintaining Accuracy and Safety Above All

US traffic-related fatalities touched a 16-year high in 2021, outstripping other major economies across the World The US Collision Industry Conference has forecast crash rates to decline by as much as 20% by 2030 on the back of widespread ADAS adoption Cepton has pioneered the use of lidar, a key sensor technology, across automotive and smart infrastructure applications. In 2019, the company was the recipient of the single largest ADAS lidar series production award with Koito on the General Motors business Cepton has now seen its lidar technology expand far beyond its initial intended use, ranging from revisioning public venues…

ThursdayAug 18, 2022 12:00 pm

DGE 2nd Omnichannel Marketing Strategy Symposium

Life science professionals are invited to attend the 2nd Omnichannel Marketing Strategy Symposium on September 29-30, 2022. Pharmaceutical, biotechnology, and medical device companies are realizing the growing importance of a powerful omnichannel marketing campaign that allows pharma to reach the right people at the right time. This intensifies the need for a substantial marketing plan. Taking into account previous impact and consumer data, marketers can concentrate on promotional spending to optimize their investment. But the vital question is, do marketers in the pharma sphere possess adequate technology and data necessary to make their omnichannel marketing as successful as it could be? The…

ThursdayAug 18, 2022 11:15 am

The Future of Zero Emission Homes, Take a Look at GeoSolar Technologies Inc.

The trend toward alternative home energy already had tailwinds and just got additional support from the new climate package passed by Congress GeoSolar Technologies is an upstart making a name for itself with a comprehensive package to build or convert homes to zero emissions GST’s home technology has been installed in multiple test homes in Colorado and achieved some of the most impressive energy efficiency ratings in the industry Every U.S. president has a legacy goal, the one thing that will always be synonymous with their name. Joe Biden has climate control high on his priority list. Sure, there are…

ThursdayAug 18, 2022 10:30 am

Friendable Inc. (FDBL) Offers a Solution to Artists Feeling Controlled and Undersupported in Today’s Music Industry

Musicians feel financially burdened by labels and streaming platforms within the industry's traditional structure Friendable's 360-degree artist platform provides the solution to help artists produce, distribute, and market their music while retaining maximum revenue Since the acquisition of Artist Republik and FeaturedX, Fan Pass Live has become the only platform offering artists a full-service option – production, distribution, and marketing with support and assistance from professionals who understand the industry Friendable (OTC: FDBL), a mobile technology company focused on its proprietary Fan Pass Live artist platform, has identified and is addressing a notable problem within the music industry for artists…

Site Search

Company Search

Category: Articles